Szabo E - Search Results

1

Pioglitazone-mediated reversal of elevated glucose metabolism in the airway epithelium of mouse lung adenocarcinomas.

Xiong D, Pan J, Zhang Q, Szabo E, Miller MS, Lubet RA, Wang Y, You M. Xiong D, et al. Among authors: szabo e. JCI Insight. 2017 Jul 6;2(13):e94220. doi: 10.1172/jci.insight.94220. eCollection 2017 Jul 6. JCI Insight. 2017. PMID: 28679956 Free PMC article.

2

Prevention of mouse lung tumors by budesonide and its modulation of biomarkers.

Pereira MA, Li Y, Gunning WT, Kramer PM, Al-Yaqoub F, Lubet RA, Steele VE, Szabo E, Tao L. Pereira MA, et al. Among authors: szabo e. Carcinogenesis. 2002 Jul;23(7):1185-92. doi: 10.1093/carcin/23.7.1185. Carcinogenesis. 2002. PMID: 12117777

3

Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes.

Lubet RA, Szabo E, Christov K, Bode AM, Ericson ME, Steele VE, Juliana MM, Grubbs CJ. Lubet RA, et al. Among authors: szabo e. Mol Cancer Ther. 2008 Apr;7(4):972-9. doi: 10.1158/1535-7163.MCT-07-2141. Epub 2008 Mar 28. Mol Cancer Ther. 2008. PMID: 18375820

4

Chemopreventive effects of pioglitazone on chemically induced lung carcinogenesis in mice.

Wang Y, James M, Wen W, Lu Y, Szabo E, Lubet RA, You M. Wang Y, et al. Among authors: szabo e. Mol Cancer Ther. 2010 Nov;9(11):3074-82. doi: 10.1158/1535-7163.MCT-10-0510. Epub 2010 Nov 2. Mol Cancer Ther. 2010. PMID: 21045137

5

Chemoprevention of lung carcinogenesis by the combination of aerosolized budesonide and oral pioglitazone in A/J mice.

Fu H, Zhang J, Pan J, Zhang Q, Lu Y, Wen W, Lubet RA, Szabo E, Chen R, Wang Y, Chen DR, You M. Fu H, et al. Among authors: szabo e. Mol Carcinog. 2011 Dec;50(12):913-21. doi: 10.1002/mc.20751. Epub 2011 Mar 3. Mol Carcinog. 2011. PMID: 21374736 Free PMC article.

6

Chemopreventive effect of a mixture of Chinese Herbs (antitumor B) on chemically induced oral carcinogenesis.

Wang Y, Yao R, Gao S, Wen W, Du Y, Szabo E, Hu M, Lubet RA, You M. Wang Y, et al. Among authors: szabo e. Mol Carcinog. 2013 Jan;52(1):49-56. doi: 10.1002/mc.20877. Epub 2011 Nov 15. Mol Carcinog. 2013. PMID: 22086836

7

Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis.

Lubet RA, Szabo E, Iwata KK, Gill SC, Tucker C, Bode A, Steele VE, Juliana MM, Nicastro HL, Grubbs CJ. Lubet RA, et al. Among authors: szabo e. Cancer Prev Res (Phila). 2013 May;6(5):448-54. doi: 10.1158/1940-6207.CAPR-12-0322. Epub 2013 Mar 26. Cancer Prev Res (Phila). 2013. PMID: 23531447 Free PMC article.

8

Bronchial airway gene expression signatures in mouse lung squamous cell carcinoma and their modulation by cancer chemopreventive agents.

Xiong D, Pan J, Zhang Q, Szabo E, Miller MS, Lubet RA, You M, Wang Y. Xiong D, et al. Among authors: szabo e. Oncotarget. 2017 Mar 21;8(12):18885-18900. doi: 10.18632/oncotarget.13806. Oncotarget. 2017. PMID: 27935865 Free PMC article.

9

Effect of weekly or daily dosing regimen of Gefitinib in mouse models of lung cancer.

Zhang Q, Li R, Chen X, Lee SB, Pan J, Xiong D, Hu J, Miller MS, Szabo E, Lubet RA, Wang Y, You M. Zhang Q, et al. Among authors: szabo e. Oncotarget. 2017 Aug 2;8(42):72447-72456. doi: 10.18632/oncotarget.19785. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 29069801 Free PMC article.

10

Novel mutational landscapes and expression signatures of lung squamous cell carcinoma.

Xiong D, Pan J, Yin Y, Jiang H, Szabo E, Lubet RA, Wang Y, You M. Xiong D, et al. Among authors: szabo e. Oncotarget. 2017 Dec 27;9(7):7424-7441. doi: 10.18632/oncotarget.23716. eCollection 2018 Jan 26. Oncotarget. 2017. PMID: 29484121 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,023 results

Search Page

Filters